| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11018675 | Journal of Dermatological Science | 2018 | 9 Pages |
Abstract
Collectively, our studies indicate that a 5 day model of IL-23 psoriasiform dermatitis can be used to assess the pharmacology of novel small molecules/biologics in the treatment of PsO.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Stephen B. Gauld, Donna Gauvin, Lauren Olson, Laura Leys, Stephanie Paulsboe, Zheng Liu, Rebecca M. Edelmayer, Joseph Wetter, Katherine Salte, Yibing Wang, Susan Huang, Prisca Honore, Steven McGaraughty,